Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of pemphigus vulgaris with mycophenolate mofetil.

× No keyword cloud information.

15 in total

1. [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].

Authors: I Elser; D Selimovic; T Ruzicka; A Kuhn; M Megahed
Journal: Hautarzt Date: 2003-10 Impact factor: 0.751

2. [IgA pemphigus. Successful treatment with mycophenolate mofetil].

Authors: T Burchardt; A Büchau; T Ruzicka; M Megahed
Journal: Hautarzt Date: 2004-04 Impact factor: 0.751

Review 3. Autoimmune bullous diseases: ocular manifestations and management.

Authors: Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 4. Seeking approval: present and future therapies for pemphigus vulgaris.

Authors: Xuming Mao; Aimee S Payne
Journal: Curr Opin Investig Drugs Date: 2008-05

5. Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.

Authors: M Shipkova; V W Armstrong; E Wieland; P D Niedmann; E Schütz; G Brenner-Weiss; M Voihsel; F Braun; M Oellerich
Journal: Br J Pharmacol Date: 1999-03 Impact factor: 8.739

6. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.

Authors: C A Jonsson; L Svensson; H Carlsten
Journal: Clin Exp Immunol Date: 1999-06 Impact factor: 4.330

Treatment of pemphigus vulgaris with mycophenolate mofetil.

1. [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].

2. [IgA pemphigus. Successful treatment with mycophenolate mofetil].

Review 3. Autoimmune bullous diseases: ocular manifestations and management.

Review 4. Seeking approval: present and future therapies for pemphigus vulgaris.

5. Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.

6. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.

7. Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.

8. Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil.

9. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.

10. Mycophenolate mofetil for myasthenia gravis: a clear and present controversy.